Parkman Healthcare Partners’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.19M | Buy |
352,262
+1,711
| +0.5% | +$34.9K | 0.83% | 48 |
|
|
2025
Q1 | $7.02M | Buy |
350,551
+45,922
| +15% | +$919K | 0.83% | 43 |
|
|
2024
Q4 | $8.12M | Buy |
304,629
+8,558
| +3% | +$228K | 1.08% | 33 |
|
|
2024
Q3 | $8.44M | Buy |
296,071
+18,176
| +7% | +$518K | 1.08% | 34 |
|
|
2024
Q2 | $6.05M | Sell |
277,895
-89,513
| -24% | -$1.95M | 0.81% | 43 |
|
|
2024
Q1 | $8.14M | Buy |
367,408
+10,252
| +3% | +$227K | 1% | 36 |
|
|
2023
Q4 | $7.71M | Buy |
357,156
+132,564
| +59% | +$2.86M | 1.09% | 31 |
|
|
2023
Q3 | $3.79M | Buy |
224,592
+76,590
| +52% | +$1.29M | 0.7% | 41 |
|
|
2023
Q2 | $2.03M | Buy |
+148,002
| New | +$2.03M | 0.35% | 75 |
|
|
2021
Q1 | – | Sell |
-22,831
| Closed | -$1.53M | – | 87 |
|
|
2020
Q4 | $1.53M | Sell |
22,831
-7,172
| -24% | -$482K | 0.39% | 65 |
|
|
2020
Q3 | $1.54M | Buy |
30,003
+5,003
| +20% | +$257K | 0.41% | 65 |
|
|
2020
Q2 | $942K | Buy |
+25,000
| New | +$942K | 0.27% | 70 |
|